Patch Testing in Non-Immediate Drug Eruptions
Open Access
- 15 June 2008
- journal article
- Published by Springer Science and Business Media LLC in Allergy, Asthma & Clinical Immunology
- Vol. 4 (2), 66-74
- https://doi.org/10.1186/1710-1492-4-2-66
Abstract
The present review addresses the literature regarding the sensitivity and specificity of the various diagnostic methods for evaluating non-immediate (ie, occurring more than 1 hour after drug administration) hypersensitivity reactions associated with β-lactams and other antibiotics, anticonvulsants, heparins, iodinated contrast media, etc. Such reactions include several clinical entities, which range from mild reactions, such as maculopapular rash and delayed-appearing urticaria, to severe ones, such as acute generalized exanthematous pustulosis (AGEP), Stevens-Johnson syndrome, and toxic epidermal necrolysis (TEN). Clinical and laboratory studies indicate that a cell-mediated pathogenic mechanism is often involved in maculopapular rashes. However, this mechanism has also been demonstrated in other non-immediate reactions, such as urticarial and/or angioedematous manifestations, TEN, bullous exanthems, and AGEP. Patch tests, together with delayed-reading intradermal tests, lymphocyte transformation tests, and challenges, are useful tools for evaluating non-immediate drug eruptions. Patch tests can be performed with any form of commercial drugs and are safer than intradermal tests. However, patch tests are less sensitive than intradermal tests, and their sensitivity may vary, depending on the vehicle used.Keywords
This publication has 50 references indexed in Scilit:
- The usefulness of skin tests to prove drug hypersensitivityBritish Journal of Dermatology, 2005
- Management of hypersensitivity reactions to iodinated contrast mediaAllergy, 2005
- Low negative predictive value of skin tests in investigating delayed reactions to radio‐contrast mediaContact Dermatitis, 2004
- Patch testing with carbamazepine and its main metabolite carbamazepine epoxide in cutaneous adverse drug reactions to carbamazepineContact Dermatitis, 2003
- Diagnosing Nonimmediate Reactions to Penicillins by in vivo TestsInternational Archives of Allergy and Immunology, 2002
- General considerations for skin test procedures in the diagnosis of drug hypersensitivityAllergy, 2002
- Delayed-type hypersensitivity skin reactions caused by subcutaneous unfractionated and low-molecular-weight heparins: Tolerance of a new recombinant hirudinJournal of the American Academy of Dermatology, 2000
- Allergic and systemic contact dermatitis from estradiolContact Dermatitis, 1999
- Adverse Skin Reactions to Low Molecular Weight HeparinsDrug Safety, 1999
- The value of the lymphocyte proliferation assay in detection of carbamazepine allergyContact Dermatitis, 1990